Single Loading Low Dose MgSo4 Regimen: A Simple, Safe and Effective Alternative to Pritchard's Regimen for Indian Women
- PMID: 28969211
- PMCID: PMC5620852
- DOI: 10.7860/JCDR/2017/26635.10453
Single Loading Low Dose MgSo4 Regimen: A Simple, Safe and Effective Alternative to Pritchard's Regimen for Indian Women
Abstract
Introduction: Magnesium sulphate is the anticonvulsant of choice in prevention and control of eclamptic convulsions. Pritchard's regimen is the most popular time-tested regimen used. However, owing to concerns of toxicity, several low dose regimens have been introduced considering the lower body mass index of Asian women.
Aim: To compare the efficacy and safety of a single loading low dose MgSo4 regimen with the Pritchard's regimen.
Materials and methods: Seventy cases of eclampsia and imminent eclampsia were allocated to the control and study groups each. The former received the Pritchard's regimen while the latter was treated with single loading low dose of magnesium sulphate. Recurrent convulsion rates, maternal and perinatal outcomes of both regimens were evaluated and compared using unpaired t-test and Chi-square test for continuous and categorical variables, respectively.
Results: The mean serum magnesium levels were significantly lower in the study group at 30 minutes and 4 hours of initiation of therapy. The single loading low dose regimen was equally efficacious in prevention (96.6% vs 100%, p = 0.934) and control (97.6% vs 97.8%, p = 0.358) of eclamptic fits as compared to the Pritchard's regimen. The feto-maternal outcomes were also comparable.
Conclusion: The single loading low dose MgSo4 regimen is an effective and safe alternative to the Pritchard's regimen, especially tailored to the small built Indian women.
Keywords: Eclampsia; Low dose magnesium sulphate; Recurrent convulsion.
Figures
Similar articles
-
Pritchard's Regimen: The Effect of 12-Hour Versus 24-Hour Magnesium Sulphate Maintenance Regimen on the Occurrence of Seizures and Maternal Outcome in Women with Severe Features of Preeclampsia: A Triple-Blind Randomized Controlled Trial.Niger Med J. 2024 Jun 20;65(3):320-331. doi: 10.60787/nmj-v65i3-434. eCollection 2024 May-Jun. Niger Med J. 2024. PMID: 39022563 Free PMC article.
-
Magnesium sulphate versus phenytoin in eclampsia - Maternal and foetal outcome - A comparative study.Australas Med J. 2013 Sep 30;6(9):483-95. doi: 10.4066/AMJ.2013.1753. eCollection 2013. Australas Med J. 2013. PMID: 24133541 Free PMC article.
-
Low-dose magnesium sulphate in the control of eclamptic fits: a randomized controlled trial.Arch Gynecol Obstet. 2013 Jan;287(1):43-6. doi: 10.1007/s00404-012-2523-z. Epub 2012 Aug 29. Arch Gynecol Obstet. 2013. PMID: 22930148 Clinical Trial.
-
Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles.Clin Pharmacokinet. 2000 Apr;38(4):305-14. doi: 10.2165/00003088-200038040-00002. Clin Pharmacokinet. 2000. PMID: 10803454 Review.
-
[Magnesium sulphate for the management of preeclampsia].Gynecol Obstet Fertil. 2006 Jan;34(1):54-9. doi: 10.1016/j.gyobfe.2005.06.025. Epub 2006 Jan 6. Gynecol Obstet Fertil. 2006. PMID: 16406662 Review. French.
Cited by
-
Perception of Midwives Towards Magnesium Sulfate Use at Chatinkha Maternity Wing in Blantyre, Malawi: A Qualitative Study.Int J Womens Health. 2020 Mar 18;12:187-196. doi: 10.2147/IJWH.S223029. eCollection 2020. Int J Womens Health. 2020. PMID: 32256123 Free PMC article.
-
Utility of Point-of-Care Ultrasound (POCUS) for predicting risk of magnesium toxicity in critically ill pre-eclamptic patients.Indian J Anaesth. 2021 Oct;65(10):760-762. doi: 10.4103/ija.ija_698_21. Epub 2021 Oct 29. Indian J Anaesth. 2021. PMID: 34898704 Free PMC article. No abstract available.
-
Health Care Readiness in Management of Preeclampsia/Eclampsia in Ethiopia: Evidence from National Facility-Based Survey.Risk Manag Healthc Policy. 2022 Jun 16;15:1225-1241. doi: 10.2147/RMHP.S366055. eCollection 2022. Risk Manag Healthc Policy. 2022. PMID: 35734013 Free PMC article.
-
Availability and use of magnesium sulphate at health care facilities in two selected districts of North Karnataka, India.Reprod Health. 2018 Jun 22;15(Suppl 1):91. doi: 10.1186/s12978-018-0531-6. Reprod Health. 2018. PMID: 29945665 Free PMC article.
References
-
- Abalos E, Cuesta C, Carroli G, Qureshi Z, Widmer M, Vogel JP, et al. WHO Multicountry Survey on Maternal and Newborn Health Research Network. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG. 2014;121(1):14–24. - PubMed
-
- Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323–33. - PubMed
-
- Jafrin W, Mia AR, Chakraborty PK, Hoque MR, Paul UK, Shaha KR, et al. An evaluation of serum magnesium status in pre-eclampsia compared to the normal pregnancy. Mymensingh Med J. 2014;23(4):649–53. - PubMed
-
- The Eclampsia Trial Collabourative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collabourative Eclampsia Trial. Lancet. 1995;345:1455–63. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources